187 related articles for article (PubMed ID: 8667698)
1. [Economic costs of autotransplantation of hematopoietic progenitors].
de Arriba F; Heras I; del Carmen Garcia M; Moraleda JM; Funes C; Ferrer F; Vicente V
Med Clin (Barc); 1996 Mar; 106(9):329-32. PubMed ID: 8667698
[TBL] [Abstract][Full Text] [Related]
2. [Economic study of the cost of peripheral blood hematopoietic precursor autotransplantation compared with bone marrow transplantation].
Juliá A; Bueno J; Gadea N; Massuet L; del Baño C
Med Clin (Barc); 1995 Jun; 105(4):131-5. PubMed ID: 7623504
[TBL] [Abstract][Full Text] [Related]
3. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
[TBL] [Abstract][Full Text] [Related]
4. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
5. Cost comparative study of autologous peripheral blood progenitor cells (PBPC) and bone marrow (ABM) transplantations for non-Hodgkin's lymphoma patients.
Woronoff-Lemsi MC; Arveux P; Limat S; Deconinck E; Morel P; Cahn JY
Bone Marrow Transplant; 1997 Dec; 20(11):975-82. PubMed ID: 9422478
[TBL] [Abstract][Full Text] [Related]
6. Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
Lobo F; Kessinger A; Landmark JD; Smith DM; Weisenburger DD; Wigton RS; Armitage JO
Bone Marrow Transplant; 1991 Nov; 8(5):389-92. PubMed ID: 1685105
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the costs for two hematopoietic cell specimen collections: cytapheresis and bone marrow collection].
Le Corroller AG; Macquart-Moulin G; Auquier P; Faucher C; Chabannon C; Blache JL; Blaise D; Novakovitch G; Maraninchi D; Moatti JP
Rev Epidemiol Sante Publique; 1996 Apr; 44(2):133-43. PubMed ID: 8693170
[TBL] [Abstract][Full Text] [Related]
8. Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC).
Bredeson C; Malcolm J; Davis M; Bence-Bruckler I; Kearns B; Huebsch L
Bone Marrow Transplant; 1997 Nov; 20(10):889-96. PubMed ID: 9404932
[TBL] [Abstract][Full Text] [Related]
9. Costs of high-dose salvage therapy and blood stem cell transplantation for resistant-relapsed malignant lymphomas in a southern Italian hospital.
Mazza P; Secondo E; Palazzo G; Amurri B; Manna N; Miloro G; Moscogiuri R
Haematologica; 1999 Feb; 84(2):142-9. PubMed ID: 10091413
[TBL] [Abstract][Full Text] [Related]
10. [Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center].
Rio B; Marjanovic Z; Belhocine R; Vekhoff A; Andrieu V; Klaren J; Boccaccio C; Delmer A; Ajchenbaum-Cymbalista F; Hunault M; Bazarbachi A; Lévy V; Andreu G; Zittoun R
Ann Med Interne (Paris); 1996; 147(5):313-9. PubMed ID: 9033732
[TBL] [Abstract][Full Text] [Related]
11. An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma.
Duncan N; Hewetson M; Powles R; Raje N; Mehta J
Bone Marrow Transplant; 1996 Dec; 18(6):1175-8. PubMed ID: 8971391
[TBL] [Abstract][Full Text] [Related]
12. [Economic evaluation of blood stem-cells autologous transplantation].
Corroller AG; Fortanier C; Faucher C; Blaise D; Moatti JP
Bull Cancer; 2001 Sep; 88(9):893-9. PubMed ID: 11604363
[TBL] [Abstract][Full Text] [Related]
13. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
14. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
[TBL] [Abstract][Full Text] [Related]
15. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
Bennett C; Waters T; Stinson T; Almagor O; Pavletic Z; Tarantolo S; Bishop M
Bone Marrow Transplant; 1999 Sep; 24(5):555-60. PubMed ID: 10482942
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
17. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.
Goterris R; Hernández-Boluda JC; Teruel A; Gómez C; Lis MJ; Terol MJ; Tormo M; Solano C; Arbona C
Bone Marrow Transplant; 2005 Nov; 36(10):847-53. PubMed ID: 16113660
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
Lefrère F; Hermine O; Audat F; Buzyn A; Cavazzana-Calvo M; Boccaccio C; Varet B
Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222
[TBL] [Abstract][Full Text] [Related]
20. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
